Despite this contentious issue, the local guidelines, supported by the international guidelines on secondary stroke prevention in 2011 have recommended the use of antihypertensive drugs, in particular ACE inhibitors as part of secondary preventive therapy in both hypertensive and normotensive patients [8, 9]. This evidence concerns the gene ACE and stroke disorder.